Recent Company News

• 07:18 AM ET Aug 10, 2026
  

  Orion notes license partner Tenax Therapeutics' Phase 3 LEVEL trial of oral levosimendan in PH-HFpEF did not reach its primary endpoint (€79.25, -2.25)

• 04:02 AM ET Aug 07, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (49 total)

• 03:56 AM ET Aug 06, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (91 total)

• 05:10 AM ET Jul 28, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (64 total)

• 03:53 AM ET Jul 23, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (53 total)

• 07:08 PM ET Jul 21, 2026
  

  President Trump states tariff on generic drugs will stay at 0% for 2 years then rise to 100% - Truth Social

• 06:21 AM ET Jul 20, 2026
  

  Orion downgraded to reduce from accumulate at OP Corporate Bank (pre-open) (€75.25, -2.15)

• 04:16 AM ET Jul 20, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:44 AM ET Jul 20, 2026
  

  StreetAccount Summary - European pre-market trading update